Quantcast
Last updated on April 16, 2014 at 4:43 EDT

Latest Macula Stories

2012-04-02 02:28:45

GREENBELT, Md., April 2, 2012 /PRNewswire-iReach/ -- Summary: Focus MaculaPro is a leading macular health vitamin in the United States and is sold in more retina specialists' offices than any other eye vitamin on the market. Focus MaculaPro up until now has only been available to patients through their retina specialist. Now, however, Covalent Medical has made Focus MaculaPro available to the general public. CovalentMedical, LLC, was started in 2011 by a group of over 400 macular...

2012-01-31 08:00:00

GREENBELT, Md., Jan. 31, 2012 /PRNewswire-iReach/ -- Summary: Over 400 retina specialists, the doctors who treat macular degeneration, start a new company called Covalent Medical, LLC to manufacture and distribute a new macular health eye vitamin called Focus MaculaPro. (Photo: http://photos.prnewswire.com/prnh/20120131/CG43611) The number of patients suffering from age-related macular degeneration is expected to skyrocket over the coming years. Age-related macular degeneration...

2011-11-18 16:56:00

Maintains clearness of vision in those with wet age-related macular degeneration SILVER SPRING, Md., Nov. 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Eylea (aflibercept) to treat patients with wet (neovascular) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) AMD gradually destroys a person's sharp, central vision. It...

2011-11-15 07:00:00

PHILADELPHIA, Nov. 15, 2011 /PRNewswire-USNewswire/ -- Researchers at Hadassah Hospital in Israel, led by Dr. Eyal Banin, have completed a clinical trial that tested the use of gene therapy to restore sight to patients suffering from Leber's Congenital Amaurosis (LCA). Dana and Yossi, two participants in this study, suffer from Leber's Congenital Amaurosis (LCA), the most severe form of all inherited retinal dystrophies causing congenital blindness. Like others affected, they have...

2011-11-10 07:25:00

ST. LOUIS, Nov. 10, 2011 /PRNewswire/ -- A recent study published in the November 2011 Journal of Optometry confirms improved vision in elderly patients through nutritional supplementation. The Zeaxanthin (zee-uh-zan-thin) and Visual Function Study (ZVF), conducted by eye nutrition pioneer Stuart Richer, PhD, OD at the Veterans Administration Hospital in Chicago, shows scientific evidence that dietary Zeaxanthin improved vision in night driving and fine detail, among others. The ZVF...

2011-10-28 07:10:00

ST. LOUIS, Oct. 28, 2011 /PRNewswire/ -- ZeaVision, LLC, makers of EyePromise® eye vitamins, is celebrating its 10-year anniversary. In 2001, Dennis Gierhart, PhD, co-founded the company with a singular mission: to fight vision loss and preserve healthy vision through superior science-based nutraceuticals and macular pigment measurement technology. ZeaVision's EyePromise brand of nutraceuticals contains all-natural ingredients, including the highest quality and level...

2011-10-24 07:10:00

ST. LOUIS, Oct. 24, 2011 /PRNewswire/ -- St. Louis-based ZeaVision, LLC announced that three recent groundbreaking studies demonstrate that Zeaxanthin (zee-uh-zan-thin), the predominate protective pigment in the back of the eye, reduces the risk for Age-Related Macular Degeneration (AMD) and benefits the treatment of advanced AMD, a condition that destroys central vision and affects millions of Americans. AMD is the leading cause of blindness in people over age 55, according to the...

2011-07-06 16:10:14

Eating a diet high in vitamin D, as well as the nutrients betaine and methionine, might help reduce the risk of macular degeneration, according to new research conducted by Tufts Medical Center scientists. Their study of identical twins from the US World War II Twin Registry also found that the more a person smoked, the higher their risk of developing macular degeneration. The study, "Smoking, Dietary Betaine, Methionine, and Vitamin D in Monozygotic Twins with Discordant Macular...

2011-06-05 18:01:00

MARLOW, England, June 6, 2011 /PRNewswire/ -- Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has recommended OZURDEX(R) (dexamethasone 0.7mg intravitreal implant in applicator) for the treatment of macular oedema due to central retinal vein occlusion (CRVO) and also for branch retinal vein occlusion (BRVO) where laser photocoagulation is neither beneficial nor appropriate. RVO is an eye condition that can lead to severe damage to the...

2011-05-16 07:30:00

MARLBOROUGH, Mass., May 16, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Casey Eye Institute (CEI) at Oregon Health & Science University (OHSU) in Portland, Ore., has received institutional review board (IRB) approval to be a site for its Phase 1/2 human clinical trial for Stargardt's Macular Dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem...